News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
642,312 Results
Type
Article (46304)
Company Profile (198)
Press Release (595810)
Multimedia
Podcasts (87)
Webinars (9)
Section
Business (182242)
Career Advice (1867)
Deals (29486)
Drug Delivery (82)
Drug Development (84295)
Employer Resources (128)
FDA (15696)
Job Trends (13475)
News (316941)
Policy (29670)
Tag
Academia (2725)
Academic (2)
Accelerated approval (6)
Adcomms (28)
Allergies (88)
Alliances (48637)
ALS (98)
Alzheimer's disease (1454)
Antibody-drug conjugate (ADC) (142)
Approvals (15674)
Artificial intelligence (287)
Autoimmune disease (23)
Automation (16)
Bankruptcy (245)
Best Places to Work (10935)
BIOSECURE Act (20)
Biosimilars (85)
Biotechnology (143)
Bladder cancer (81)
Brain cancer (30)
Breast cancer (300)
Cancer (2374)
Cardiovascular disease (192)
Career advice (1597)
Career pathing (24)
CAR-T (161)
Cell therapy (459)
Cervical cancer (22)
Clinical research (68850)
Collaboration (858)
Compensation (460)
Complete response letters (26)
COVID-19 (2645)
CRISPR (43)
C-suite (247)
Cystic fibrosis (102)
Data (2305)
Decentralized trials (2)
Denatured (33)
Depression (48)
Diabetes (271)
Diagnostics (6408)
Digital health (15)
Diversity (8)
Diversity, equity & inclusion (38)
Drug discovery (127)
Drug pricing (73)
Drug shortages (25)
Duchenne muscular dystrophy (95)
Earnings (72553)
Editorial (37)
Employer branding (15)
Employer resources (113)
Events (99505)
Executive appointments (710)
FDA (17013)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (766)
Gene editing (113)
Generative AI (31)
Gene therapy (326)
GLP-1 (703)
Government (4032)
Grass and pollen (5)
Guidances (106)
Healthcare (18010)
Huntington's disease (24)
IgA nephropathy (29)
Immunology and inflammation (126)
Indications (30)
Infectious disease (2786)
Inflammatory bowel disease (153)
Inflation Reduction Act (8)
Influenza (55)
Intellectual property (96)
Interviews (320)
IPO (14186)
IRA (33)
Job creations (2965)
Job search strategy (1346)
Kidney cancer (11)
Labor market (26)
Layoffs (412)
Leadership (19)
Legal (6331)
Liver cancer (77)
Lung cancer (337)
Lymphoma (154)
Machine learning (8)
Management (43)
Manufacturing (296)
MASH (69)
Medical device (12290)
Medtech (12295)
Mergers & acquisitions (15895)
Metabolic disorders (677)
Multiple sclerosis (83)
NASH (18)
Neurodegenerative disease (109)
Neuropsychiatric disorders (25)
Neuroscience (2019)
NextGen: Class of 2025 (6046)
Non-profit (4231)
Now hiring (25)
Obesity (343)
Opinion (235)
Ovarian cancer (78)
Pain (94)
Pancreatic cancer (88)
Parkinson's disease (154)
Partnered (21)
Patents (224)
Patient recruitment (119)
Peanut (46)
People (51747)
Pharmaceutical (45)
Pharmacy benefit managers (10)
Phase I (21752)
Phase II (30327)
Phase III (22433)
Pipeline (1263)
Policy (128)
Postmarket research (2669)
Preclinical (8786)
Press Release (60)
Prostate cancer (113)
Psychedelics (37)
Radiopharmaceuticals (260)
Rare diseases (392)
Real estate (5263)
Recruiting (50)
Regulatory (21430)
Reports (34)
Research institute (2527)
Resumes & cover letters (282)
Rett syndrome (5)
RNA editing (5)
RSV (34)
Schizophrenia (73)
Series A (136)
Series B (90)
Service/supplier (10)
Sickle cell disease (54)
Special edition (13)
Spinal muscular atrophy (153)
Sponsored (29)
Startups (3259)
State (2)
Stomach cancer (15)
Supply chain (57)
Tariffs (29)
The Weekly (53)
Vaccines (706)
Venture capitalists (34)
Weight loss (215)
Women's health (32)
Worklife (14)
Date
Today (290)
Last 7 days (828)
Last 30 days (2814)
Last 365 days (31951)
2025 (11112)
2024 (34310)
2023 (38761)
2022 (49050)
2021 (52638)
2020 (50849)
2019 (43618)
2018 (32922)
2017 (31150)
2016 (30309)
2015 (35256)
2014 (28320)
2013 (23970)
2012 (24993)
2011 (25225)
2010 (23776)
Location
Africa (786)
Alabama (56)
Alaska (6)
Arizona (167)
Arkansas (13)
Asia (38365)
Australia (6888)
California (6050)
Canada (1899)
China (530)
Colorado (269)
Connecticut (276)
Delaware (138)
Europe (87674)
Florida (863)
Georgia (201)
Idaho (53)
Illinois (473)
India (25)
Indiana (297)
Iowa (8)
Japan (165)
Kansas (99)
Kentucky (25)
Louisiana (10)
Maine (48)
Maryland (864)
Massachusetts (4547)
Michigan (209)
Minnesota (338)
Mississippi (1)
Missouri (77)
Montana (29)
Nebraska (22)
Nevada (59)
New Hampshire (63)
New Jersey (1684)
New Mexico (29)
New York (1723)
North Carolina (1005)
North Dakota (8)
Northern California (2664)
Ohio (204)
Oklahoma (14)
Oregon (30)
Pennsylvania (1341)
Puerto Rico (8)
Rhode Island (30)
South America (1076)
South Carolina (23)
Southern California (2284)
Tennessee (97)
Texas (908)
United States (22649)
Utah (181)
Virginia (150)
Washington D.C. (58)
Washington State (540)
West Virginia (3)
Wisconsin (52)
642,312 Results for "clinical and laboratory standards institute".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Pharm Country
The Clinical and Laboratory Standards Institute Announces the Publication of New Antimicrobial Susceptibility Testing Documents CLSI M100-Ed34, M02-Ed14, and M07-Ed12
The Clinical and Laboratory Standards Institute (CLSI) has released a new update of CLSI M100—Performance Standards for Antimicrobial Susceptibility Testing, 34th Edition and revised editions of CLSI M02—Performance Standards for Antimicrobial Disk Susceptibility Tests, 14th Edition and CLSI M07—Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically, 12th Edition.
March 26, 2024
·
2 min read
Oncovita and Institut Pasteur announce the creation of a joint laboratory dedicated to cancer immunotherapy and prophylactic vaccinology
Oncovita and Institut Pasteur announce the creation of a joint laboratory dedicated to cancer immunotherapy and prophylactic vaccinology
May 29, 2024
·
3 min read
Press Releases
NYU Langone Sets the Standard for Highest Quality Pediatric Kidney and Liver Transplant Programs in New York
May 2, 2025
·
4 min read
Cancer
BMS, Pfizer Challenge Colorectal Cancer Standard Care With ASCO GI Readouts
Bristol Myers Squibb’s Opdivo plus Yervoy, as well as Pfizer’s Braftovi, have each shown strong Phase III performances that could position them as new standards of care in certain subtypes of metastatic colorectal cancer.
January 27, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Standard BioTools Announces New Product Innovations in Plasma and Single-Cell Proteomics at AACR 2025
April 24, 2025
·
4 min read
Press Releases
Icotrokinra Clinical Study Results Demonstrate Its Potential to Shift Treatment Paradigm and Set a New Standard for Treatment in Plaque Psoriasis
March 10, 2025
·
16 min read
Press Releases
Standard BioTools Reports First Quarter 2025 Financial Results
May 7, 2025
·
16 min read
Press Releases
Nanostics Receives CPSA Accreditation for its Newly Relocated Clinical Laboratory at the Biotechnology Business Development Centre in Edmonton
April 16, 2025
·
4 min read
Press Releases
Tasso and ARUP Laboratories Announce Partnership, Combined Offering for Decentralized Clinical Research Biomarker Testing
February 3, 2025
·
3 min read
Press Releases
Kairos Pharma Adds Huntsman Cancer Institute for Phase 2 ENV105 Clinical Trial
February 12, 2025
·
3 min read
1 of 64,232
Next
